Key result
The subcutaneous implantable cardioverter-defibrillator provides effective defibrillation while avoiding intravascular hardware complications, with new algorithms reducing inappropriate shocks.
The S-ICD is an established therapy with evolving implantation techniques and device algorithms that improve safety, reduce inappropriate shocks, and minimize the need for general anesthesia.
The use of subcutaneous implantable cardioverter-defibrillators (S-ICDs) has increased over time. Device-based algorithms have been developed to reduce inappropriate shocks. New implant techniques have been developed including the two-incision technique and the placement of the generator submuscularly. More patients are being implanted without general anesthesia. This review summarizes the newest S-ICD features, surgical implantation methods, and device-related safety and efficacy findings.
No takes yet. Share an insight, caveat, or question.
Zeineh et al. (2018) conducted a review in Patients requiring implantable cardioverter-defibrillator therapy. Subcutaneous implantable cardioverter-defibrillator (S-ICD) was evaluated. The subcutaneous implantable cardioverter-defibrillator provides effective defibrillation while avoiding intravascular hardware complications, with new algorithms reducing inappropriate shocks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: